Exacerbation (treatment during next 3y) | All (n = 2501) | |||
---|---|---|---|---|
No (n = 421) | Yes (n = 2080) | p | ||
Agea | 65.62 (11.90) | 68.94 (11.50) | 0.001 | 68.38 (11.60) |
COPD History (years)a | 2.86 (3.50) | 3.69 (4.40) | 0.001 | 3.55 (4.30) |
Num. of visits (2009)a | 18.01 (14.30) | 25.96 (18.70) | 0.001 | 24.63 (18.30) |
FEV1 | 66.38 (23.20) | 62.80 (24.40) | 0.004 | 63.38 (24.30) |
Gender (female)b | 79 (18.76 %) | 547 (26.30 %) | 0.001 | 626 (25.03 %) |
23-valent Pneumococcalb | 242 (57.48 %) | 1520 (73.08 %) | 0.001 | 1762 (70.45 %) |
2009 influenza vaccineb | 242 (57.48 %) | 1544 (74.23 %) | 0.001 | 1786 (71.41 %) |
Exacerbation 2009b | 20 (4.75 %) | 486 (23.37 %) | 0.001 | 506 (20.23 %) |
Number of comorbiditiesc | 0.34 (0.70) | 0.45 (0.70) | 0.002 | 0.43 (0.70) |
Smokingb | 178 (42.28 %) | 666 (32.02 %) | 0.001 | 844 (33.75 %) |
Gold (Severity)b | 0.062 | |||
Mild COPD | 223 (52.97 %) | 1048 (50.38 %) | 1271 (50.82 %) | |
Moderate COPD | 157 (37.29 %) | 726 (34.90 %) | 883 (35.31 %) | |
Severe COPD | 27 (6.41 %) | 209 (10.05 %) | 236 (9.44 %) | |
Very Severe COPD | 14 (3.33 %) | 97 (4.66 %) | 111 (4.44 %) | |
Hospital Admissionb | 62 (14.73 %) | 750 (36.06 %) | 0.001 | 812 (32.47 %) |
Deathb | 39 (9.26 %) | 275 (13.22 %) | 0,025 | 314 (12.55 %) |